Evidence map›Paper›PMID 25267584›Full record

Observational studyHeart rhythm2015

Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: The PRIMERI Study.

Theingi Tiffany Win, Bharath Ambale Venkatesh, Gustavo J Volpe, Nathan Mewton, Patricia Rizzi, Ravi K Sharma, David G Strauss, Joao A Lima, Larisa G Tereshchenko

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Heart rhythm, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 3 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta-analysis.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2020
    Pooled it
  4. Article
  5. Prevalence, associated factors, and prognostic value of P wave abnormality in patients with coronary artery disease.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Atrial Cardiomyopathy: From Diagnosis to Treatment.Reviews in cardiovascular medicine · 2025
    Review
  11. The effect of fixed and functional remodelling on conduction velocity, wavefront propagation, and rotational activity formation in atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  12. Article
  13. Review
  14. Association of electrocardiographic spatial heterogeneity of repolarization and spatial heterogeneity of atrial depolarization with left ventricular fibrosis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  15. Article
  16. Article
  17. Prognostic value of P-wave morphology in general population.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Theingi Tiffany WinDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Cardiology, Department of Medicine, University of New Mexico, Albuquerque, New Mexico.
Bharath Ambale VenkateshDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Gustavo J VolpeDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Nathan MewtonDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Patricia RizziDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ravi K SharmaDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
David G StraussU.S. Food and Drug Administration, Silver Spring, Maryland.
Joao A LimaDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Larisa G TereshchenkoDivision of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland; The Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: tereshch@ohsu.edu.
Johns Hopkins Medicine · USJohns Hopkins University · USUnited States Food and Drug Administration · US

Funding

Novel ECG Measures and Risk of Sudden Cardiac DeathR01HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2013 to 2016
$1.5M
PRIMARY ECG - MRI RISK STRATIFICATIONP20HL101397 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI LIMA, JOAO A C · 2010 to 2011
$1.4M
NHLBI NIH HHS 1R01HL118277NHLBI NIH HHS P20 HL101397NHLBI NIH HHS P20HL101397NHLBI NIH HHS R01 HL118277
6 · The paper itself

Abstract

backgroundAbnormal P-terminal force in lead V1 (PTFV1) is associated with an increased risk of heart failure, stroke, atrial fibrillation, and death.

objectiveOur goal was to explore associations of left ventricular (LV) diffuse fibrosis with left atrial (LA) function and electrocardiographic (ECG) measures of LA electrical activity.

methodsPatients without atrial fibrillation (n = 91; mean age 59.5 years; 61.5% men; 65.9% white) with structural heart disease (spatial QRS-T angle ≥105° and/or Selvester QRS score ≥5 on ECG) but LV ejection fraction >35% underwent clinical evaluation, cardiac magnetic resonance, and resting ECG. LA function indices were obtained by multimodality tissue tracking using 2- and 4-chamber long-axis images. T1 mapping and late gadolinium enhancement were used to assess diffuse LV fibrosis and presence of scar. P-prime in V1 amplitude (PPaV1) and duration (PPdV1), averaged P-wave-duration, PR interval, and P-wave axis were automatically measured using 12 SLTM algorithm. PTFV1 was calculated as a product of PPaV1 and PPdV1.

resultsIn linear regression after adjustment for demographic characteristics, body mass index, maximum LA volume index, presence of scar, and LV mass index, each decile increase in LV interstitial fibrosis was associated with 0.76 mV*ms increase in negative abnormal PTFV1 (95% confidence interval [CI] -1.42 to -0.09; P = .025), 15.3 ms prolongation of PPdV1 (95% CI 6.9 to 23.8; P = .001) and 5.4 ms prolongation of averaged P-duration (95% CI 0.9-10.0; P = .020). LV fibrosis did not affect LA function. PPaV1 and PTFV1 were associated with an increase in LA volumes and decrease in LA emptying fraction and LA reservoir function.

conclusionLV interstitial fibrosis is associated with abnormal PTFV1, prolonged PPdV1, and P-duration, but does not affect LA function.

Indexed as

AgedAtrial FibrillationAtrial Function, LeftCohort StudiesElectrocardiographyEndomyocardial FibrosisFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRisk FactorsAtrial fibrillationFibrosisLeft atrium functionLeft ventricleP-terminal force in V(1)

Identifiers

PMID25267584
PMCPMC4277898
OpenAlexW2006470883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.